Marex Investors Urged to Act as Class Action Nears Dec. 8 Lead-Plaintiff Deadline

Overview

• Rosen Law Firm, Berger Montague, and DJS Law Group are inviting shareholders to seek lead-plaintiff status by December 8, 2025.
• The putative class covers purchases of Marex securities from May 16, 2024 through August 5, 2025.
• Complaints cite allegations from an August 5 NINGI Research report, including self-dealing OTC trades, inconsistent intercompany receivables and loans, a fabricated $17 million receivable, an asset marked at $14.9 million later sold for $2.5 million, and nearly $1 billion in off-balance-sheet derivatives exposure tied to a Luxembourg fund.
• After the report was published, Marex shares fell $2.33, or 6.2%, to close at $35.31 on unusually heavy volume.
• Notices reference Exchange Act Sections 10(b) and 20(a) and SEC Rule 10b-5, and emphasize that no class has been certified and the allegations have not been proven.